- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
Summary: Testing drug levels
- Poor treatment adherence is a major cause of poor drug levels.
- Interactions between drugs can influence drug levels.
- Some people's bodies get rid of drugs faster than others.
- Low drug levels in the blood may cause treatment to fail.
- A small number of treatment centres are testing drug levels in people taking protease inhibitors.
- Higher drug levels may mean greater anti-HIV activity but more severe and more frequent side-effects.
latest aidsmap news
- 'ART as prevention tool' policy announced for British Columbia
- <i>The Lancet</i>: HIV is a global disaster
- Important changes to nevirapine dosing advice made by FDA
- Fatty liver in patients with HIV associated with metabolic abnormalities
- Most HIV infections in Zambia and Rwanda happen in marriage: prevention programmes for couples recommended
- HIV-positive Caribbean people in the UK experience high levels of stigma
- Poverty and unemployment common amongst HIV-positive Londoners
- Risk of death for people with HIV now similar to that seen in the general population
- Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV
- Asymptomatic anal HPV infection more common than thought in heterosexual men